Search research articles
Contact Us
Filters
Showing results (101-110 of 124) with videos related to
Page
of 13
Sort By:
Molecular Cancer Therapeutics
|
May 11, 2019
Targeting PARP-1 with Alpha-Particles Is Potently Cytotoxic to Human Neuroblastoma in Preclinical Models
Mehran Makvandi, Hwan Lee, Laura N Puentes, et al.
The Journal of Clinical Investigation
|
March 7, 2018
A PET imaging agent for evaluating PARP-1 expression in ovarian cancer
Mehran Makvandi, Austin Pantel, Lauren Schwartz, et al.
American Journal of Clinical Oncology
|
June 11, 2020
ACR-ACNM-ASTRO-SNMMI Practice Parameter for the Performance of Therapy With Radium-223
Mark Hurwitz, John R Buscombe, Heather A Jacene, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
October 7, 2018
Efficacy and Safety of High-Specific-Activity <sup>131</sup>I-MIBG Therapy in Patients with Advanced Pheochromocytoma or Paraganglioma
Daniel A Pryma, Bennett B Chin, Richard B Noto, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
December 15, 2019
Breast Cancer <sup>18</sup>F-ISO-1 Uptake as a Marker of Proliferation Status
Elizabeth S McDonald, Robert K Doot, Anthony J Young, et al.
Pancreas
|
May 3, 2021
The North American Neuroendocrine Tumor Society Consensus Guidelines for Surveillance and Management of Metastatic and/or Unresectable Pheochromocytoma and Paraganglioma
Lauren Fishbein, Jaydira Del Rivero, Tobias Else, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
October 30, 2024
Kinetic Analysis and Metabolism of Poly(Adenosine Diphosphate-Ribose) Polymerase-1-Targeted <sup>18</sup>F-Fluorthanatrace PET in Breast Cancer
Anthony J Young, Austin R Pantel, Mahsa Kiani, et al.
Communications Biology
|
November 18, 2022
Pre-clinical investigation of astatine-211-parthanatine for high-risk neuroblastoma
Mehran Makvandi, Minu Samanta, Paul Martorano, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
July 19, 2011
(124)I-huA33 antibody PET of colorectal cancer
Jorge A Carrasquillo, Neeta Pandit-Taskar, Joseph A O'Donoghue, et al.
American Journal of Clinical Oncology
|
May 4, 2022
ACR-ACNM-ASTRO-SNMMI Practice Parameter for Lutetium-177 (Lu-177) DOTATATE Therapy
Charito Love, Neil B Desai, Tony Abraham, et al.
Page
of 13
Search research articles
Search
Showing results (101-110 of 124) with videos related to
Sort By:
Page
of 13
Molecular Cancer Therapeutics
|
May 11, 2019
Targeting PARP-1 with Alpha-Particles Is Potently Cytotoxic to Human Neuroblastoma in Preclinical Models
Mehran Makvandi, Hwan Lee, Laura N Puentes, et al.
The Journal of Clinical Investigation
|
March 7, 2018
A PET imaging agent for evaluating PARP-1 expression in ovarian cancer
Mehran Makvandi, Austin Pantel, Lauren Schwartz, et al.
American Journal of Clinical Oncology
|
June 11, 2020
ACR-ACNM-ASTRO-SNMMI Practice Parameter for the Performance of Therapy With Radium-223
Mark Hurwitz, John R Buscombe, Heather A Jacene, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
October 7, 2018
Efficacy and Safety of High-Specific-Activity <sup>131</sup>I-MIBG Therapy in Patients with Advanced Pheochromocytoma or Paraganglioma
Daniel A Pryma, Bennett B Chin, Richard B Noto, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
December 15, 2019
Breast Cancer <sup>18</sup>F-ISO-1 Uptake as a Marker of Proliferation Status
Elizabeth S McDonald, Robert K Doot, Anthony J Young, et al.
Pancreas
|
May 3, 2021
The North American Neuroendocrine Tumor Society Consensus Guidelines for Surveillance and Management of Metastatic and/or Unresectable Pheochromocytoma and Paraganglioma
Lauren Fishbein, Jaydira Del Rivero, Tobias Else, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
October 30, 2024
Kinetic Analysis and Metabolism of Poly(Adenosine Diphosphate-Ribose) Polymerase-1-Targeted <sup>18</sup>F-Fluorthanatrace PET in Breast Cancer
Anthony J Young, Austin R Pantel, Mahsa Kiani, et al.
Communications Biology
|
November 18, 2022
Pre-clinical investigation of astatine-211-parthanatine for high-risk neuroblastoma
Mehran Makvandi, Minu Samanta, Paul Martorano, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
July 19, 2011
(124)I-huA33 antibody PET of colorectal cancer
Jorge A Carrasquillo, Neeta Pandit-Taskar, Joseph A O'Donoghue, et al.
American Journal of Clinical Oncology
|
May 4, 2022
ACR-ACNM-ASTRO-SNMMI Practice Parameter for Lutetium-177 (Lu-177) DOTATATE Therapy
Charito Love, Neil B Desai, Tony Abraham, et al.
Page
of 13